e-Article

	o	ㅋ	ㄱ	ㅅ	ㅈ	ㅌ	ㄷ	촉	ㄴ	ㅎ	ㅂ	ㅃ	ㅁ	야	ㄹ	와
ㅏ	あ a	ぁ	か ka	が ga	さ sa	ざ za	た ta	だ da		な na	は ha	ば ba	ぱ pa	ま ma	や ya	ゃ lya	ら ra	わ wa	ゎ lwa	ん n
l	い i	ぃ	き ki	ぎ gi	し si	じ zi	ち ti	ぢ di		に ni	ひ hi	び bi	ぴ pi	み mi			り ri
ㅜ	う u	ぅ	く ku	ぐ gu	す su	ず zu	つ tu	づ du	っ	ぬ nu	ふ hu	ぶ bu	ぷ pu	む mu	ゆ yu	ゅ lyu	る ru
ㅔ	え e	ぇ	け ke	げ ge	せ se	ぜ ze	て te	で de		ね ne	へ he	べ be	ぺ pe	め me			れ re
ㅗ	お o	ぉ	こ ko	ご go	そ so	ぞ zo	と to	ど do		の no	ほ ho	ぼ bo	ぽ po	も mo	よ yo	ょ lyo	ろ ro	を wo

	o	ㅋ	ㄱ	ㅅ	ㅈ	ㅌ	ㄷ	촉	ㄴ	ㅎ	ㅂ	ㅃ	ㅁ	야	ㄹ	와
ㅏ	ア a	ァ	カ ka	ガ ga	サ sa	ザ za	タ ta	ダ da		ナ na	ハ ha	バ ba	パ pa	マ ma	ヤ ya	ャ lya	ラ ra	ワ wa	ヮ lwa		ン n
l	イ i	ィ	キ ki	ギ gi	シ si	ジ zi	チ ti	ヂ di		ニ ni	ヒ hi	ビ bi	ピ pi	ミ mi			リ ri
ㅜ	ウ u	ゥ	ク ku	グ gu	ス su	ズ zu	ツ tu	ヅ du	ッ	ヌ nu	フ hu	ブ bu	プ pu	ム mu	ユ yu	ュ lyu	ル ru			ヴ vu
ㅔ	エ e	ェ	ケ ke	ゲ ge	セ se	ゼ ze	テ te	デ de		ネ ne	ヘ he	ベ be	ぺ pe	メ me			レ re
ㅗ	オ o	ォ	コ ko	ゴ go	ソ so	ゾ zo	ト to	ド do		ノ no	ホ ho	ボ bo	ポ po	モ mo	ヨ yo	ョ lyo	ロ ro	ヲ wo		ーー

독일어
ä	Ä	ö	Ö	ü	Ü	ß
프랑스어
á	à	Á	À	é	è	É	È	ç	Ç	ê
스페인어
à	á	Á	é	É	í	Í	Ó	ó	Ú	ú	Ñ	ñ	ä	Ä

Publication date	- (ex : 2010-2015)

Select All

Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia

Academic Journal

Vistisen, D; Carstensen, B; Elisabetta, P; Lanzinger, S; Tan, ECH; Yabe, D; Kim, DJ; Sheu, WHH; Melzer-Cohen, C; Holl, RW; Nunez, J; Ha, KH; Halvorsen, S; Langslet, G; Karasik, A; Nystrom, T; Niskanen, L; Guleria, S; Klement, R; Carrasco, M; Foersch, J; Shay, C; Koeneman, L; Hoti, F; Farsani, SF; Khunti, K; Zaccardi, F; Subramanian, A; Nirantharakumar, K

Cardiovascular diabetology. 22(1):233

EBSCOHost PDF Full Text (Gale Academic Onefile) Full Text (ProQuest Central) Open Access (SwePub) Open Access (BioMed Central) Web of Science JCR 저널정보 Scopus Find it@PNU

Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study

Academic Journal

Karasik, A; Lanzinger, S; Tan, ECH; Yabe, D; Kim, DJ; Sheu, WHH; Melzer-Cohen, C; Holl, RW; Ha, KH; Khunti, K; Zaccardi, F; Subramanian, A; Nirantharakumar, K; Nystrom, T; Niskanen, L; Jensen, ML; Hoti, F; Klements, R; Deruaz-Luyet, A; Kyaw, MH; Koeneman, L; Vistisen, D; Carstensen, B; Halvorsen, S; Langslet, G; Farsani, SF; Patorno, E; Nunez, J

Diabetes & metabolism. 49(2):101418

Full Text (ScienceDirect 종량제) Full Text (Clinical Key) Open Access (SwePub) Web of Science JCR 저널정보 Find it@PNU

PHS13 - Clinical Inertia in Type 2 Diabetes Mellitus: Time in Poor Glycaemic Control Until Treatment Intensification in Patients on DPP-4I And/Or SGLT-2I Treatment

Academic Journal

Lanzinger, S; Kalscheuer, H; Welp, R; Zimmermann, A; Propp, S; Fasching, P; Wagner, S; Holl, RW

In Value in Health October-November 2017 20(9):A495-A495

Full Text (ScienceDirect) Full Text (Clinical Key) Full Text (ScienceDirect O/A) Web of Science JCR 저널정보 Scopus Find it@PNU

Return to Sport After Criteria-Based Rehabilitation of Acute Adductor Injuries in Male Athletes: A Prospective Cohort Study

Electronic Resource

Serner, A; Weir, Adam; Tol, JL; Thorborg, K; Lanzinger, S; Otten, R; Holmich, P

Serner , A , Weir , A , Tol , JL , Thorborg , K , Lanzinger , S , Otten , R & Holmich , P 2020 , ' Return to Sport After Criteria-Based Rehabilitation of Acute Adductor Injuries in Male Athletes: A Prospective Cohort Study ' , Orthopaedic Journal of Sports Medicine , vol. 8 , no. 1 , 2325967119897247 .

Open Access (OAIster)